Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.
An advanced theoretical model of vibration-induced Raynaud’s phenomenon suggests that vibrations cause capillary walls in the hand to thicken, leading to what is known as hand-arm vibration syndrome (HAVS). ... Read more
Tracleer (bosentan) combined with Ventavis (iloprost) reduced abnormalities in the tiny blood vessels in the hands of patients with scleroderma who often experience Raynaud’s phenomenon as a consequence of ... Read more
Patients with both primary and secondary Raynaud’s phenomenon have an abnormally low blood penetration in the heart tissue, which likely explains the increased death rates from heart disease in ... Read more
Acupressure does not appear to be an effective way of managing Raynaud’s phenomenon, according to a small clinical trial comparing the intervention to patient education. The trial (NCT01784354) also noted that ... Read more
Internal organ damage from scleroderma tends to occur early in the disease course and simultaneously, rather than in sequences, for patients who develop the disease soon after the onset of Raynaud’s phenomenon, according to ... Read more
Norepinephrine signaling, believed to contribute to Raynaud’s phenomenon, also may be driving fibrosis development in patients with scleroderma, according to a study that opens up for new research into ... Read more
Sufficient data does not exist to assess if botulinum toxin is effective in treating symptoms of Raynaud’s phenomenon, a review of previously published studies concluded. The report, “Botulinum toxin A ... Read more